Robert W. Naismith

In addition to his role at Life Sciences Greenhouse, Dr. Naismith has served as Chairman and Chief Executive Officer of Roosevelt Capital Partners, LLC since January of 2008.
Prior to that, he was Chairman and Chief Executive Officer of Life Science Analytics, Inc. He also founded the NEPA Medical Education Development Consortium.
He served as Senior Vice President and Managing Director for Datamonitor Inc. in New York.
Dr. Naismith founded Biofor, Inc. a biopharmaceutical company, and served as its President, CEO, and Director, which he later sold to Scherer Healthcare.
He co-founded Pharmakon Research International.
Dr. Naismith also served as Chairman of the Healthcare and Scientific Advisory Board at BlueStone Capital Partners, LP, in New York form October 1996 to January 1998.
In 1998, he founded Emedsecurities, a boutique investment ban serving the small-cap life sciences industry that was the predecessor to Life Science Analytics.
Dr. Naismith has served on the board of directors for Penseco Financial Services Corp., Biofor, Inc. and William Harvey Medical Research Foundation.
He is also an adjunct professor at the School of Medicine at Case Western Reserve University.
He served as director for the Scranton Temple Residency Program.
Dr. Naismith holds a PhD in Genetics from Pennsylvania State University and a BA in Biology from East Stroudsburg University.